Kefir Production Using Segmented Microbial Strains
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Commercial kefir products lack the microbial diversity and specific yeast and bacterial species found in traditional kefir, which are essential for conferring health benefits such as cholesterol reduction and improved metabolic health, making them less effective than traditional kefir in improving circulating cholesterol levels and non-alcoholic fatty liver disease markers.
Innovation Solution
A method involving the use of specific bacterial strains like Acetobacter, Leuconostoc, and Lactobacillus, and yeast strains like Pichia, Saccharomyces, and Kluyveromyces, added to pasteurized milk for fermentation, replicating the microbial composition of traditional kefir to produce a kefir product with enhanced health benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional kefir grains are used for fermentation, then the microbial diversity and health benefits are improved, but the production scalability and commercial viability are worsened
Solution Approach 1:
The patent segments the complex kefir grain microbial community into individual bacterial and yeast strains that can be separately cultured and controlled. This allows the microbial consortium to be divided into discrete components (Lactobacillus, Lactococcus, Leuconostoc, Saccharomyces, Pichia, Kluyveromyces) that can be independently managed for large-scale production while maintaining the synergistic health benefits of the complete community.
Solution Approach 2:
The patent creates a replicated version of traditional kefir by identifying and culturing the specific microbial strains that compose kefir grains. Instead of using the original kefir grain structure, the invention copies the functional microbial community through separate strain cultivation and combination, enabling commercial-scale production that replicates the health benefits of traditional kefir.
2Reliability
If kefir grains are stored and maintained for production, then the fermentation capability is preserved, but the storage requirements and operational complexity are increased
Solution Approach 1:
The patent segments the kefir grain system into individual bacterial and yeast strains that can be stored separately under optimized conditions for each organism type. This eliminates the need to maintain complex kefir grain structures, allowing each strain to be cultured, stored, and revived independently, significantly simplifying operational procedures and storage requirements.
Solution Approach 2:
The patent performs preliminary culturing and characterization of each microbial strain before production. The strains are pre-adapted and stored in optimized media conditions, so that when production is needed, the fermentation capability is already prepared and activated, eliminating the need for ongoing kefir grain maintenance and storage during production cycles.
3Productivity
If commercial kefir production methods are used, then the production efficiency is improved, but the microbial composition accuracy and health benefit delivery are worsened
Solution Approach 1:
The patent applies parameter changes by optimizing cultivation conditions (temperature, pH, media composition, incubation time) for each specific bacterial and yeast strain. This allows precise control over the microbial composition of the final kefir product, ensuring that the correct strains are present in appropriate proportions to deliver the desired health benefits while maintaining efficient production.
Solution Approach 2:
The patent implements feedback mechanisms through microbial identification and characterization at each production stage. By monitoring the presence and activity of specific strains (Lactobacillus, Lactococcus, Leuconostoc, Saccharomyces, Pichia, Kluyveromyces), the process can be adjusted to ensure accurate microbial composition, guaranteeing that the final product contains the correct consortium for health benefit delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method results in a kefir product that effectively reduces cholesterol and liver triglycerides, mirroring the benefits of traditional kefir, and is suitable for commercial-scale production, demonstrating the importance of microbial composition in kefir's health impacts.
Implementation Method 1
the use of kefir grains allows for only small scale production of kefir through the symbiotic fermentation of milk by lactic acid bacteria and yeasts
Data Source
AI summary
A method for preparing a kefir product involves providing bacterial strains selected from Acetobacter, Leuconostoc, Lactococcus, or Lactobacillus; providing yeast strains selected from Pichia, Saccharomyces, Kazachstania, or Kluyveromyces; adding the bacterial and yeast strains to milk to form a mixture; and allowing the mixture to ferment to yield the kefir product.